Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
Authors
Keywords
Liposarcoma, Patient-derived orthotopic xenograft, PDOX, PDGFRA amplification, Trabectedin, Precision medicine
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-20
DOI
10.1186/s12885-018-4703-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models
- (2018) Kentaro Igarashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Apatinib for advanced sarcoma: results from multiple institutions’ off-label use in China
- (2018) Lu Xie et al. BMC CANCER
- Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma
- (2018) Filippo Spriano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma
- (2018) Kentaro Igarashi et al. CANCER LETTERS
- Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy
- (2018) Kentaro Igarashi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model
- (2018) Tasuku Kiyuna et al. TISSUE & CELL
- MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model
- (2018) Kei Kawaguchi et al. TISSUE & CELL
- Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
- (2017) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer
- (2017) Jean-Philippe Adam et al. GYNECOLOGIC ONCOLOGY
- Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
- (2017) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
- (2017) Kentaro Igarashi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
- (2017) Kei Kawaguchi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
- (2017) Audrey Laroche et al. Journal of Hematology & Oncology
- PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models
- (2017) Ymera Pignochino et al. Molecular Cancer
- Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies
- (2017) Mitsuru Takahashi et al. ONCOLOGIST
- Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model
- (2017) Kentaro Igarashi et al. Oncotarget
- A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology
- (2017) Kentaro Igarashi et al. Oncotarget
- Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma
- (2017) Takaaki Nakai et al. Cancer Medicine
- Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma
- (2017) Yevette McGovern et al. Frontiers in Oncology
- Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study
- (2016) Fernando A. Angarita et al. BMC CANCER
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient-derived xenografts: a relevant preclinical model for drug development
- (2016) Luca Pompili et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model
- (2016) Mako Yamamoto et al. PLoS One
- Liposarcoma
- (2016) Aimee M. Crago et al. Surgical Oncology Clinics of North America
- Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model
- (2016) Takashi Murakami et al. Oncotarget
- High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model
- (2016) Tasuku Kiyuna et al. Oncotarget
- The value of trabectedin in the treatment of soft tissue sarcoma
- (2016) Tomoki Nakamura et al. Therapeutics and Clinical Risk Management
- Managing Liposarcomas: Cutting Through the Fat
- (2016) Gulam A. Manji et al. Journal of Oncology Practice
- Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group
- (2015) J. Khalifa et al. BMC CANCER
- BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
- (2015) A Laroche-Clary et al. BRITISH JOURNAL OF CANCER
- Unique features of trabectedin mechanism of action
- (2015) Annette K. Larsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial
- (2015) B. Bui-Nguyen et al. EUROPEAN JOURNAL OF CANCER
- Establishment of a Patient-Derived Orthotopic Xenograft (PDOX) Model of HER-2-Positive Cervical Cancer Expressing the Clinical Metastatic Pattern
- (2015) Yukihiko Hiroshima et al. PLoS One
- Advances in the targeted therapy of liposarcoma
- (2015) Guan et al. OncoTargets and Therapy
- Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
- (2015) Rita De Sanctis et al. Drug Design Development and Therapy
- Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models
- (2015) Yukihiko Hiroshima et al. Oncotarget
- Successful Fluorescence-Guided Surgery on Human Colon Cancer Patient-Derived Orthotopic Xenograft Mouse Models Using a Fluorophore-Conjugated Anti-CEA Antibody and a Portable Imaging System
- (2014) Yukihiko Hiroshima et al. Journal of Laparoendoscopic & Advanced Surgical Techniques
- Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer
- (2014) Yukihiko Hiroshima et al. JOURNAL OF SURGICAL ONCOLOGY
- Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore
- (2014) Yukihiko Hiroshima et al. PLoS One
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model
- (2013) Cristina A. Metildi et al. JOURNAL OF SURGICAL ONCOLOGY
- Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results
- (2013) William Tseng et al. Cancers
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
- (2011) A. Gronchi et al. ANNALS OF ONCOLOGY
- ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma
- (2011) Antoine Italiano et al. CANCER
- Pleomorphic liposarcoma
- (2011) Markus P. Ghadimi et al. CANCER
- Systemic Management Strategies for Metastatic Soft Tissue Sarcoma
- (2011) Sujana Movva et al. DRUGS
- Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
- (2011) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Orbital Pleomorphic Liposarcoma in an Eight-Year-Old Boy
- (2011) Erin Rudzinski et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- (2010) G. Germano et al. CANCER RESEARCH
- Radiological-pathological correlation of pleomorphic liposarcoma of the anterior mediastinum in a 17-year-old girl
- (2010) Maysa Saeed et al. PEDIATRIC RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now